Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
CNS Drugs
|
July 28, 2011
Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management
James J Gugger
The American Journal on Addictions
|
September 5, 2008
Low-dose quetiapine is not a benign sedative-hypnotic agent
James J Gugger, Manouchkathe Cassagnol
Neurology
|
May 1, 2023
Toward a Patient-Specific Readout of Neurodegeneration: The Case for Spatial Normative Modeling in Alzheimer Disease
Nishant Sinha, James J Gugger
JAMA Neurology
|
February 21, 2022
Early Posttraumatic Seizures-Putting Things in Perspective
James J Gugger, Ramon Diaz-Arrastia
The Annals of Pharmacotherapy
|
June 18, 2009
Delirium in a patient with toxic flecainide plasma concentrations: the role of a pharmacokinetic drug interaction with paroxetine
Yvonne Y Tsao, James J Gugger
The Annals of Pharmacotherapy
|
September 8, 2005
Percutaneous coronary intervention-related bleeding risk factors in current practice
A Scott Mathis, James J Gugger
The Annals of Pharmacotherapy
|
October 11, 2007
Rapid eye movement sleep behavior disorder
James J Gugger, Mary L Wagner
The Journal of ECT
|
February 6, 2019
Subarachnoid Hemorrhage in the Setting of Electroconvulsive Therapy in a Patient With an Unsecured Cerebral Aneurysm: A Case Report and Review of the Literature
James J Gugger, Lauren E Dunn
Neurocritical Care
|
April 29, 2022
The Frontier of Electrophysiologic Monitoring in Acute Brain Injury
James J Gugger, Ramon Diaz-Arrastia
Journal of Pharmacy Practice
|
November 4, 2011
Neuroleptic-induced catatonia in two hospitalized patients
James J Gugger, Maha Saad, Candace Smith
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
CNS Drugs
|
July 28, 2011
Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management
James J Gugger
The American Journal on Addictions
|
September 5, 2008
Low-dose quetiapine is not a benign sedative-hypnotic agent
James J Gugger, Manouchkathe Cassagnol
Neurology
|
May 1, 2023
Toward a Patient-Specific Readout of Neurodegeneration: The Case for Spatial Normative Modeling in Alzheimer Disease
Nishant Sinha, James J Gugger
JAMA Neurology
|
February 21, 2022
Early Posttraumatic Seizures-Putting Things in Perspective
James J Gugger, Ramon Diaz-Arrastia
The Annals of Pharmacotherapy
|
June 18, 2009
Delirium in a patient with toxic flecainide plasma concentrations: the role of a pharmacokinetic drug interaction with paroxetine
Yvonne Y Tsao, James J Gugger
The Annals of Pharmacotherapy
|
September 8, 2005
Percutaneous coronary intervention-related bleeding risk factors in current practice
A Scott Mathis, James J Gugger
The Annals of Pharmacotherapy
|
October 11, 2007
Rapid eye movement sleep behavior disorder
James J Gugger, Mary L Wagner
The Journal of ECT
|
February 6, 2019
Subarachnoid Hemorrhage in the Setting of Electroconvulsive Therapy in a Patient With an Unsecured Cerebral Aneurysm: A Case Report and Review of the Literature
James J Gugger, Lauren E Dunn
Neurocritical Care
|
April 29, 2022
The Frontier of Electrophysiologic Monitoring in Acute Brain Injury
James J Gugger, Ramon Diaz-Arrastia
Journal of Pharmacy Practice
|
November 4, 2011
Neuroleptic-induced catatonia in two hospitalized patients
James J Gugger, Maha Saad, Candace Smith
Page
of 5